Drug Profile


Alternative Names: Invicorp; Phentolamine/aviptadil; PSD 510; Vasopotin

Latest Information Update: 20 Apr 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Senetek
  • Developer Evolan Pharma; Plethora Solutions; Senetek
  • Class Gastrointestinal hormones; Imidazoles; Neuropeptides; Peptide hormones; Vasodilators
  • Mechanism of Action Alpha adrenergic receptor antagonists; Vasoactive intestinal peptide receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Erectile dysfunction

Most Recent Events

  • 20 Apr 2017 Launched for Erectile dysfunction in Finland (Intracavernous) before April 2017 (Fimea website, April 2017)
  • 20 Apr 2017 No recent reports on development identified - Preregistration for Erectile dysfunction in Germany (Intracavernous)
  • 03 Apr 2015 Preregistration for Erectile dysfunction in United Kingdom, Germany, Sweden, Finland and Norway (Intracavernous) before April 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top